BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32657873)

  • 1. Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma.
    Causa Andrieu PI; Das JP; Woo S; Ryan R; Akin O; Ulaner GA
    Clin Nucl Med; 2020 Nov; 45(11):873-875. PubMed ID: 32657873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare Extramedullary Cardiac Involvement of Recurrent Multiple Myeloma Suspected on 18F-FDG and Confirmed on 18F-Fluorocholine.
    Zhang-Yin J; Garderet L; Martino S; Montravers F; Talbot JN
    Clin Nucl Med; 2020 Nov; 45(11):916-918. PubMed ID: 32796239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Myeloma of Testes and Spermatic Cord on 18F-FDG PET/CT.
    Velaga J; Liang HH; Gopalakrishnan SK
    Clin Nucl Med; 2019 Apr; 44(4):297-298. PubMed ID: 30688733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Extramedullary Involvement Site in Patients With Multiple Myeloma: Stomach.
    Gülbahar Ateş S; Uçmak G
    Clin Nucl Med; 2022 Nov; 47(11):e702-e703. PubMed ID: 35619203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of
    Pan B; Wang SC; Zhan FL; Ni M; Liu X; Zhang YF; Xie Q; Xie JK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):189-194. PubMed ID: 35123625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET-CT in Adrenal Multiple Myeloma.
    Choudhury S; Purandare N; Agrawal A; Shah S; Rangarajan V
    Clin Nucl Med; 2018 Sep; 43(9):691-692. PubMed ID: 30015660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Infiltration of Multiple Myeloma With Initial Manifestation of Cavernous Sinus Syndrome Unveiled by 18F-FDG PET/CT.
    Li C; Shao F; Yang Y; Lan X
    Clin Nucl Med; 2019 Sep; 44(9):746-747. PubMed ID: 31306198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-Myelomatosis of the Brachial Plexus - An Unusual Site of Disease Visualized by FDG-PET/CT: A Case Report.
    Fukunaga H; Mutoh T; Tatewaki Y; Shimomura H; Totsune T; Terao C; Miyazawa H; Taki Y
    Am J Case Rep; 2017 May; 18():478-481. PubMed ID: 28458390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.
    Tirumani SH; Sakellis C; Jacene H; Shinagare AB; Munshi NC; Ramaiya NH; Van den Abbeele AD
    Clin Nucl Med; 2016 Jan; 41(1):e7-13. PubMed ID: 26252323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Whole-Body DWI and
    Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
    AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma.
    Caldarella C; Annunziata S; Pagano L; De Stefano V; Rufini V
    Clin Nucl Med; 2017 Feb; 42(2):e130-e134. PubMed ID: 27922862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body (18)F-FDG PET identifies high-risk myeloma.
    Durie BG; Waxman AD; D'Agnolo A; Williams CM
    J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent Liver and Mesentery Primary Extraosseous Multiple Myeloma on 18F-FDG PET/CT.
    Carnahan MB; Larsen JT; Conley CR; Yang M
    Clin Nucl Med; 2021 Feb; 46(2):e100-e102. PubMed ID: 33086271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass-forming extramedullary hematopoiesis in multiple myeloma: 18F-FDG PET/CT is useful in excluding extramedullary myeloma involvement.
    Seo M; Kim H; Jo JC; Choi Y; Cha HJ; Lim JH; Park SH
    Tumori; 2016 Nov; 102(Suppl. 2):116-118. PubMed ID: 26429647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Baseline
    Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
    Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of
    Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
    Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle Involvement of Multiple Myeloma Revealed by FDG PET/CT.
    Liang M; Su M; Wang R; Wang W; Fan C
    Clin Nucl Med; 2017 Apr; 42(4):300-302. PubMed ID: 28195903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.